Atomwise

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera's Cash & More

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera's Cash & More

2 monthes ago   |   Xconomy

The financial markets are tumbling , event cancellations are mounting , and sports leagues are suspending their seasons. March Madness is in full swing but not in any way that...
Read more ...

Bio Roundup: Biogen at CTAD, Sage's Stumble, Astellas's $3B Offer & More

Bio Roundup: Biogen at CTAD, Sage's Stumble, Astellas's $3B Offer & More

5 monthes ago   |   Xconomy

It's been a roller-coaster year for those hoping for new drugs to treat Alzheimer's disease, a leading cause of death with rising treatment costs and no clear answer yet as to...
Read more ...

Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI

Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI

5 monthes ago   |   Xconomy

Two venture-backed startups that have developed technologies intended to speed up the drug discovery and development process are combining those tools in a bid to achieve their...
Read more ...

Startup X-37 Raises $14.5M to Expand on AI-Powered Drug Discovery

Startup X-37 Raises $14.5M to Expand on AI-Powered Drug Discovery

6 monthes ago   |   Xconomy

Launched just last year, artificial intelligence-powered drug discovery company X-37 now has raised $14.5 million in Series A financing to expand its development programs...
Read more ...

Five Years After Y Combinator First Admits Biotechs, They're Dug In

Five Years After Y Combinator First Admits Biotechs, They're Dug In

7 monthes ago   |   Xconomy

Five years ago, the big tech incubator Y Combinator started to welcome life sciences companies into its sizable startup classes, which had previously nurtured entrepreneurs in...
Read more ...

A.I. for Healthcare Gets Even More Crowded as GV Invests in Owkin

A.I. for Healthcare Gets Even More Crowded as GV Invests in Owkin

2 years ago   |   Xconomy

More money continues to flow into startups seeking to harness the massive amount of data available in healthcare using artificial intelligence and machine learning. This time...
Read more ...

Atomwise Raises $45M To Grow AI-Driven Drug Discovery Business

Atomwise Raises $45M To Grow AI-Driven Drug Discovery Business

2 years ago   |   Xconomy

Atomwise , a San Francisco startup that's using artificial intelligence to hunt for compounds that could make effective new drugs, announced today that it raised a $45 million...
Read more ...

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

2 years ago   |   Xconomy

The investment arm of biotech giant Amgen has led a new $6 million round of funding in GNS Healthcare, CEO Colin Hill tells Xconomy. Amgen Ventures' new investment is a part of...
Read more ...

Mayo Clinic and Boston Software Maker Add Qrativ to Busy A.I. Sector

Mayo Clinic and Boston Software Maker Add Qrativ to Busy A.I. Sector

2 years ago   |   Xconomy

Artificial intelligence systems have become a trendy, but useful means of extracting meaning out of the troves of scientific research and clinical data that institutions...
Read more ...

Monsanto And Atomwise Collaborate To Discover New Crop Protection Options Using Artificial Intelligence Technology

2 years ago   |   BioSpace

Life Sciences Jobs ...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational treatments for sickle cell... Read more ...

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the... Read more ...

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine fibroids. The regulatory... Read more ...

Daya Bay Reactor Experiment Continues to Generate Data

Daya Bay Reactor Experiment Continues to Generate Data

Antineutrino detectors are submersed in liquid at the Daya Bay experiment, as seen during the final phase of construction in August 2012. Experiment: Daya Bay reactor neutrino... Read more ...

Seeing Cancer, But Not Through a Microscope

Seeing Cancer, But Not Through a Microscope

Toward the end of the 19th century, a French doctor named Ernest Besnier coined the term “ biopsy ,” combining the Greek bios and opsis. In the decades since, clinicians have... Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national... Read more ...

Don't Wait for “Them” to Find Your Weaknesses

Don't Wait for “Them” to Find Your Weaknesses

Our Professional Services Written by: Crystal Booth, M.M.- Regional Manager, Southeast USA at PSC Biotech We've probably all heard the phrase “audit ready state”. But what does... Read more ...

Functional oral nanoparticles for delivering silibinin and cryptotanshinone...

Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor... Read more ...

Escherichia coli metabolism under short-term repetitive substrate dynamics...

Microbial metabolism is highly dependent on the environmental conditions. Especially, the substrate concentration, as well as oxygen availability, determine the metabolic... Read more ...

High-yield production of l-serine through a novel identified exporter...

L-Serine has wide and increasing applications in industries with fast-growing market demand. Although strategies for achieving and improving l-serine production in... Read more ...